MyFinsight
Home
Blog
About
Contact
Download
Download image
Neuroscience Group
$2,562M
(4.53%↑ Y/Y)
Medical Surgical
$2,171M
(2.02%↑ Y/Y)
Medical
Surgical-Surgical Endoscopy
$1,679M
(1.82%↑ Y/Y)
Diabetes Group
$757M
(10.35%↑ Y/Y)
Neuroscience
Group-Specialty Therapies...
$744M
(0.95%↑ Y/Y)
Neuromodulation
Division-Neuroscience Group
$520M
(8.33%↑ Y/Y)
Acute Care
Monitoring-Medical Surgical
$493M
(3.14%↑ Y/Y)
Total Reportable
Segments
$8,926M
(6.69%↑ Y/Y)
All Other Segments
$35M
(-5.41%↓ Y/Y)
Net sales
$8,961M
(6.64%↑ Y/Y)
Operating profit
$1,686M
(5.71%↑ Y/Y)
Other non-operating
income, net
$92M
(-46.82%↓ Y/Y)
Cost of products
sold, excluding...
$3,061M
(3.90%↑ Y/Y)
Selling, general, and
administrative expense
$2,965M
(7.54%↑ Y/Y)
Research and development
expense
$754M
(8.18%↑ Y/Y)
Amortization of intangible
assets
$463M
(12.11%↑ Y/Y)
Other operating
expense (income), net
-$22M
(-164.71%↓ Y/Y)
Restructuring charges, net
$10M
(-66.67%↓ Y/Y)
Income before income
taxes
$1,597M
(2.44%↑ Y/Y)
Interest expense, net
$181M
(-13.40%↓ Y/Y)
Net income
$1,381M
(8.06%↑ Y/Y)
Income tax provision
$215M
(-23.49%↓ Y/Y)
Net income
attributable to medtronic
$1,374M
(8.19%↑ Y/Y)
Net income
attributable to...
$7M
(-22.22%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Medtronic_logo-svg (2)-svg
Medtronic plc (MDT)
Medtronic_logo-svg (2)-svg
Medtronic plc (MDT)